Treatment of Hypertrophic Osteoarthropathy With Underlying Pulmonary Adenocarcinoma Using Zoledronic Acid.
University of Texas Southwestern Medical School Dallas, TX isamu.tachibana@utsouthwestern.edu.
Isamu
I
Tachibana
Divya
D
Gehi
Craig D
CD
Rubin
D000230:Adenocarcinoma / Q000150:complications / Q000473:pathology / Q000601:surgery; D000077192:Adenocarcinoma of Lung; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D008175:Lung Neoplasms / Q000150:complications / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D059408:Pain Management; D010147:Pain Measurement; D011013:Pneumonectomy / Q000379:methods*; D016896:Treatment Outcome; D000077211:Zoledronic Acid
D000701:Analgesics, Opioid; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D007093:Imidazoles; D000077211:Zoledronic Acid